These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 4273095

  • 1. Mithramycin therapy in Paget's disease.
    Russell AS, Lentle BC.
    Can Med Assoc J; 1974 Feb 16; 110(4):397-400. PubMed ID: 4273095
    [Abstract] [Full Text] [Related]

  • 2. Mithramycin in the treatment of Paget's disease of bone.
    Elias EG, Evans JT.
    J Bone Joint Surg Am; 1972 Dec 16; 54(8):1730-6. PubMed ID: 4265871
    [No Abstract] [Full Text] [Related]

  • 3. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A, Lemaire V, Tubiana M.
    Rev Rhum Mal Osteoartic; 1975 Nov 16; 42(11):693-8. PubMed ID: 131365
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A, Mermillod B, Schenk R, Courvoisier B, Burkhardt P, Epiney J, Fleisch.
    Schweiz Med Wochenschr; 1976 Nov 27; 106(48):1667-73. PubMed ID: 827810
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I, Shapiro B, Ostrum B, Beller ML.
    Clin Orthop Relat Res; 1977 Nov 27; (122):347-58. PubMed ID: 402246
    [Abstract] [Full Text] [Related]

  • 6. Ascorbic acid therapy for the relief of bone pain in Paget's disease.
    Basu TK, Smethurst M, Gillett MB, Donaldson D, Jordan SJ, Williams DC, Hicklin JA.
    Acta Vitaminol Enzymol; 1978 Nov 27; 32(1-4):45-9. PubMed ID: 582875
    [Abstract] [Full Text] [Related]

  • 7. [Paget disease of the skeleton. Internal medicine aspects].
    Ziegler R, Baldauf G.
    Radiologe; 1984 Sep 27; 24(9):401-7. PubMed ID: 6238341
    [Abstract] [Full Text] [Related]

  • 8. Mithramycin in Paget's disease.
    Epstein S.
    S Afr Med J; 1974 Jun 09; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract] [Full Text] [Related]

  • 9. Long term effectiveness of low dose mithramycin for Paget's disease of bone.
    Russell AS, Chalmers IM, Percy JS, Lentle BC.
    Arthritis Rheum; 1979 Mar 09; 22(3):215-8. PubMed ID: 154331
    [Abstract] [Full Text] [Related]

  • 10. [Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease].
    Hadjipavlou AG, Danais S, Greenwood F, Siller TN, Tsoukas GM.
    Union Med Can; 1978 Sep 09; 107(9):849-56. PubMed ID: 151960
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C, Chapuy MC, Bressot C, Vignon E, Arlot M, Mathieu L, Edouard C, Johnston CC, Meunier PJ.
    Nouv Presse Med; 1980 Nov 29; 9(45):3429-33. PubMed ID: 6777752
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Paget's disease with mithramycin: further experiences.
    Ryan WG, Schwartz TB, Northrop G.
    Semin Drug Treat; 1972 Nov 29; 2(1):57-64. PubMed ID: 4261785
    [No Abstract] [Full Text] [Related]

  • 13. [Biological exploration of Paget's disease].
    Eisinger J, Laponche AM, Roux H, Recordier AM.
    Rev Rhum Mal Osteoartic; 1976 Feb 29; 43(2):105-11. PubMed ID: 131366
    [Abstract] [Full Text] [Related]

  • 14. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb 29; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic progress--review VII. The medical treatment of Paget's disease.
    Sheppard MC.
    J Clin Hosp Pharm; 1983 Mar 29; 8(1):35-44. PubMed ID: 6221033
    [Abstract] [Full Text] [Related]

  • 16. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec 29; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 17. Determinants of remission of Paget's disease of bone.
    Patel S, Stone MD, Coupland C, Hosking DJ.
    J Bone Miner Res; 1993 Dec 29; 8(12):1467-73. PubMed ID: 8304048
    [Abstract] [Full Text] [Related]

  • 18. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
    Condon JR, Surtees J, Robinson V.
    Postgrad Med J; 1981 Feb 29; 57(664):84-8. PubMed ID: 6455656
    [Abstract] [Full Text] [Related]

  • 19. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K, Merry P, Scott DG.
    J Rheumatol; 1994 Nov 29; 21(11):2118-21. PubMed ID: 7869320
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.